All Stories

  1. Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program

    Article • The Oncologist, November 2017, Alphamed Press

    Adam Dicker

  2. Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

    Article • Cancer, October 2017, Wiley

    Adam Dicker

  3. The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

    Article • Journal for ImmunoTherapy of Cancer, April 2017, Springer Science + Business Media

    Adam Dicker

  4. PD24-07 EFFICACY AND SAFETY OF RADIUM-223 BY RADICAL LOCAL THERAPY AT INITIAL DIAGNOSIS: A RETROSPECTIVE SUBGROUP ANALYSIS OF ALSYMPCA TRIAL

    Article • The Journal of Urology, April 2017, Elsevier

    Adam Dicker

  5. Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

    Article • Journal of Clinical Oncology, March 2017, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  6. A pilot study to determine if the use of a virtual reality education module reduces anxiety and increases comprehension in patients receiving radiation therapy

    Article • Journal of Radiation Oncology, March 2017, Springer Science + Business Media

    Adam Dicker

  7. IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling

    Article • Molecular Cancer Research, March 2017, American Association for Cancer Research (AACR)

    Adam Dicker

  8. Capturing the patient voice in radiotherapy trials: An analysis of trends and future directions of patient-reported outcomes.

    Article • Journal of Clinical Oncology, February 2017, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  9. mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice

    Article • American Society of Clinical Oncology Educational Book, January 2017, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  10. Disbiosis microbiana en las bronquiectasias y la fibrosis quística

    Article • Archivos de Bronconeumología, January 2017, Elsevier

    Adam Dicker

  11. Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery

    Article • Technology in Cancer Research & Treatment, December 2016, SAGE Publications

    Adam Dicker

  12. RB Loss Promotes Prostate Cancer Metastasis

    Article • Cancer Research, December 2016, American Association for Cancer Research (AACR)

    Adam Dicker, Adam Snook

  13. Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics

    Article • Practical Radiation Oncology, December 2016, Elsevier

    Adam Dicker

  14. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2016, Elsevier

    Adam Dicker, Prof. Gopal Shukla

  15. Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs

    Article • Journal of Applied Clinical Medical Physics, September 2016, Wiley

    Adam Dicker

  16. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation

    Article • Oncotarget, August 2016, Impact Journals, LLC

    Adam Dicker

  17. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer

    Article • American Journal of Clinical Oncology, August 2016, Wolters Kluwer Health

    Adam Dicker

  18. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

    Article • European Urology, July 2016, Elsevier

    Adam Dicker

  19. Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma

    Article • American Journal of Clinical Oncology, April 2016, Wolters Kluwer Health

    Adam Dicker

  20. Quality and Reporting Accuracy of Phase 1 Drug Radiation Clinical Trials

    Article • JAMA Oncology, March 2016, American Medical Association (AMA)

    Adam Dicker

  21. A single activity with a practice quality improvement project for faculty and a quality improvement project for residents

    Article • Practical Radiation Oncology, March 2016, Elsevier

    Adam Dicker

  22. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities

    Article • American Journal of Clinical Oncology, March 2016, Wolters Kluwer Health

    Adam Dicker

  23. Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife

    Article • Frontiers in Oncology, February 2016, Frontiers

    Adam Dicker

  24. CNS Metastases in Patients With Non–Small-Cell Lung Cancer and ALK Gene Rearrangement

    Article • Journal of Clinical Oncology, January 2016, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  25. Effect of caloric restriction on the efficacy of radiation in both hormone-sensitive and hormone-resistant prostate cancers.

    Article • Journal of Clinical Oncology, January 2016, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  26. Evaluating the quality, clinical relevance, and resident perception of the radiation oncology in-training examination: A national survey

    Article • Practical Radiation Oncology, January 2016, Elsevier

    Adam Dicker

  27. Abstract A93: The Smac mimetic Debio 1143 synergizes with radiotherapy and immune checkpoint inhibitors to enhance antitumor immunity

    Article • Molecular Cancer Therapeutics, December 2015, American Association for Cancer Research (AACR)

    Adam Dicker

  28. RTRB-14TREATMENT RECOMMENDATIONS FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA LACK WORLDWIDE CONSENSUS

    Article • Neuro-Oncology, November 2015, Oxford University Press (OUP)

    Adam Dicker

  29. Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes

    Article • European Urology, October 2015, Elsevier

    Adam Dicker

  30. Social Media and Oncology: The Past, Present, and Future of Electronic Communication Between Physician and Patient

    Article • Seminars in Oncology, October 2015, Elsevier

    Adam Dicker

  31. Modernizing Eligibility Criteria for Molecularly Driven Trials

    Article • Journal of Clinical Oncology, September 2015, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  32. Abstract 283: Smac mimetic and radiotherapy synergize to enhance antitumor immunity in lung cancer by targeting immunosuppressive cells

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Adam Dicker

  33. Abstract 5054: Discerning the PARP-dependent AR cistrome/transcriptome in prostate cancer

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Adam Dicker

  34. Abstract 1843: Novel actions of next-generation taxanes benefit advanced stages of prostate cancer

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Adam Dicker

  35. X-ray Diffraction Investigations of Shape Memory NiTi Wire

    Article • Journal of Materials Engineering and Performance, June 2015, Springer Science + Business Media

    Adam Dicker

  36. Reply to C.G. Rusthoven et al

    Article • Journal of Clinical Oncology, June 2015, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  37. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2015, Elsevier

    Adam Dicker

  38. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation

    Article • Radiotherapy and Oncology, June 2015, Elsevier

    Adam Dicker

  39. Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis

    Article • PLoS ONE, April 2015, PLOS

    Adam Dicker

  40. African-American Race Is a Predictor of Seminal Vesicle Invasion After Radical Prostatectomy

    Article • Clinical Genitourinary Cancer, April 2015, Elsevier

    Adam Dicker

  41. MP6-03 A NOVEL BIOMARKER SIGNATURE WHICH MAY PREDICT AGGRESSIVE DISEASE IN AFRICAN-AMERICAN MEN WITH PROSTATE CANCER

    Article • The Journal of Urology, April 2015, Elsevier

    Adam Dicker

  42. MP1-12 COMPARATIVE ANALYSIS OF AFRICAN AMERICAN AND EUROPEAN AMERICAN MEN USING A PROSTATE CANCER GENOMIC CLASSIFIER

    Article • The Journal of Urology, April 2015, Elsevier

    Adam Dicker

  43. MP55-18 RACE IMPACTS ETS FAMILY TRANSCRIPTION FACTOR EXPRESSION IN PROSTATE CANCER: DATA FROM A MULTI-INSTITUTIONAL COHORT

    Article • The Journal of Urology, April 2015, Elsevier

    Adam Dicker

  44. Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy

    Article • Journal of Clinical Oncology, March 2015, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  45. Assessing Adverse Events of Postprostatectomy Radiation Therapy for Prostate Cancer: Evaluation of Outcomes in the Regione Emilia-Romagna, Italy

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2015, Elsevier

    Adam Dicker

  46. Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort

    Article • PLoS ONE, February 2015, PLOS

    Adam Dicker

  47. Novel Actions of Next-Generation Taxanes Benefit Advanced Stages of Prostate Cancer

    Article • Clinical Cancer Research, February 2015, American Association for Cancer Research (AACR)

    Adam Dicker

  48. Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features

    Article • American Journal of Clinical Oncology, February 2015, Wolters Kluwer Health

    Adam Dicker

  49. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men

    Article • Urologic Oncology Seminars and Original Investigations, February 2015, Elsevier

    Adam Dicker

  50. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies

    Article • American Journal of Clinical Oncology, February 2015, Wolters Kluwer Health

    Adam Dicker

  51. American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment

    Article • Journal of Clinical Oncology, January 2015, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  52. Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

    Article • Seminars in Radiation Oncology, January 2015, Elsevier

    Adam Dicker

  53. Control of Shape Memory Alloy Actuated Flexible Needle Using Multimodal Sensory Feedbacks

    Article • Journal of Automation and Control Engineering, January 2015, EJournal Publishing

    Adam Dicker

  54. 3D Motion Planning for Robot-Assisted Active Flexible Needle Based on Rapidly-Exploring Random Trees

    Article • Journal of Automation and Control Engineering, January 2015, EJournal Publishing

    Adam Dicker

  55. Is robotic arm stereotactic body radiation therapy ‘virtual high-dose rate brachytherapy’ effective for prostate cancer? An analysis of comparative effectiveness using published data

    Article • Expert Review of Medical Devices, December 2014, Taylor & Francis

    Adam Dicker

  56. Adjuvant Radiation for Node-Positive Disease After Prostatectomy: More Good News, but Who Will Listen?

    Article • Journal of Clinical Oncology, December 2014, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  57. Toward an Improved Understanding of the Ionizing Radiation Induced DNA Damage/Response Networks in Human Malignancies

    Article • Frontiers in Oncology, December 2014, Frontiers

    Adam Dicker

  58. Minimizing morbidity in radiation oncology: a special issue from Future Oncology

    Article • Future Oncology, December 2014, Future Medicine

    Adam Dicker

  59. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    Article • The Lancet Oncology, December 2014, Elsevier

    Adam Dicker

  60. Radiation Protection of the Gastrointestinal Tract and Growth Inhibition of Prostate Cancer Xenografts by a Single Compound

    Article • Molecular Cancer Therapeutics, November 2014, American Association for Cancer Research (AACR)

    Adam Dicker

  61. Converting a clinical indicator on patient missed treatments into a functional quality improvement metric.

    Article • Journal of Clinical Oncology, October 2014, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  62. Process mapping and time study to improve efficiency of HDR prostate brachytherapy.

    Article • Journal of Clinical Oncology, October 2014, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  63. A Tissue Biomarker-Based Model That Identifies Patients with a High Risk of Distant Metastasis and Differential Survival by Length of Androgen Deprivation Therapy in RTOG Protocol 92-02

    Article • Clinical Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Adam Dicker

  64. A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2014, Elsevier

    Adam Dicker

  65. AAPM and GEC-ESTRO guidelines for image-guided robotic brachytherapy: Report of Task Group 192

    Article • Medical Physics, September 2014, Wiley

    Adam Dicker

  66. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma

    Article • Brachytherapy, September 2014, Elsevier

    Adam Dicker

  67. The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness

    Article • Clinical Cancer Research, August 2014, American Association for Cancer Research (AACR)

    Adam Dicker

  68. The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?

    Article • British Journal of Cancer, August 2014, Nature

    Adam Dicker

  69. Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2014, Elsevier

    Adam Dicker

  70. Development of a coordinated controller for robot-assisted shape memory alloy actuated needle for prostate brachytherapy

    Article • August 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Adam Dicker

  71. Path planning for robot-assisted active flexible needle using improved Rapidly-Exploring Random trees

    Article • August 2014, Institute of Electrical & Electronics Engineers (IEEE)

    Adam Dicker

  72. microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response

    Article • Frontiers in Oncology, June 2014, Frontiers

    Adam Dicker

  73. Study of Unrecovered Strain and Critical Stresses in One-Way Shape Memory Nitinol

    Article • Journal of Materials Engineering and Performance, May 2014, Springer Science + Business Media

    Adam Dicker

  74. High-Priority Topics for Cancer Quality Measure Development: Results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit

    Article • Journal of Oncology Practice, May 2014, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  75. The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905

    Article • PLoS ONE, April 2014, PLOS

    Adam Dicker

  76. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

    Article • Journal of Neuro-Oncology, April 2014, Springer Science + Business Media

    Adam Dicker

  77. High dose rate brachytherapy boost for prostate cancer: A systematic review

    Article • Cancer Treatment Reviews, April 2014, Elsevier

    Adam Dicker

  78. Radiation therapy and the immune system: learning to live together

    Article • Future Oncology, April 2014, Future Medicine

    Adam Dicker

  79. The quality frontier

    Article • Future Oncology, March 2014, Future Medicine

    Adam Dicker

  80. A model to predict deflection of bevel-tipped active needle advancing in soft tissue

    Article • Medical Engineering & Physics, March 2014, Elsevier

    Adam Dicker

  81. Yttrium-90 Microsphere Brachytherapy for Liver Metastases from Uveal Melanoma

    Article • Brachytherapy, March 2014, Elsevier

    Adam Dicker

  82. The Antiangiogenic Effects of a Vascular Endothelial Growth Factor Decoy Receptor Can Be Monitored in Vivo Using Contrast-Enhanced Ultrasound Imaging

    Article • Molecular Imaging, March 2014, Decker, Inc.

    Adam Dicker

  83. Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets

    Article • British Journal of Cancer, February 2014, Nature

    Adam Dicker

  84. A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect

    Article • PLoS ONE, February 2014, PLOS

    Adam Dicker

  85. Treatment‐related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity‐modulated versus conformal radiation therapy

    Article • Cancer Medicine, February 2014, Wiley

    Adam Dicker

  86. Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma

    Article • Journal of Cancer Research and Clinical Oncology, February 2014, Springer Science + Business Media

    Adam Dicker

  87. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer

    Article • Future Oncology, February 2014, Future Medicine

    Adam Dicker

  88. The impact of body mass index on treatment recommendations for patients with intermediate risk prostate cancer.

    Article • Journal of Clinical Oncology, February 2014, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  89. Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

    Article • International Journal of Radiation Oncology*Biology*Physics, January 2014, Elsevier

    Adam Dicker

  90. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?

    Article • Expert Review of Anticancer Therapy, January 2014, Informa Healthcare

    Adam Dicker

  91. Polyacrylamide phantom for self-actuating needle–tissue interaction studies

    Article • Medical Engineering & Physics, January 2014, Elsevier

    Adam Dicker

  92. Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

    Article • Journal of Clinical Oncology, December 2013, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  93. Patterns of Care for Elderly Men Diagnosed With Favorable-risk Prostate Cancer From 2004 to 2008

    Article • American Journal of Clinical Oncology, December 2013, Wolters Kluwer Health

    Adam Dicker

  94. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer

    Article • Expert Review of Medical Devices, November 2013, Informa Healthcare

    Adam Dicker

  95. Systematic review of hypofractionated radiation therapy for prostate cancer

    Article • Cancer Treatment Reviews, November 2013, Elsevier

    Adam Dicker

  96. The Responsibilities of a Chief Resident in Radiation Oncology: Results of a National Survey

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2013, Elsevier

    Adam Dicker

  97. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab

    Article • Cancer Biology & Therapy, October 2013, Taylor & Francis

    Adam Dicker

  98. Correction: Identifying Barriers to Patient Acceptance of Active Surveillance: Content Analysis of Online Patient Communications

    Article • PLoS ONE, September 2013, PLOS

    Adam Dicker

  99. A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult

    Article • Cancer Discovery, September 2013, American Association for Cancer Research (AACR)

    Adam Dicker

  100. Identifying Barriers to Patient Acceptance of Active Surveillance: Content Analysis of Online Patient Communications

    Article • PLoS ONE, September 2013, PLOS

    Adam Dicker

  101. Evolution of advanced technologies in prostate cancer radiotherapy

    Article • Nature Reviews Urology, September 2013, Nature

    Adam Dicker

  102. In Reply to Franken and Barendsen

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2013, Elsevier

    Adam Dicker

  103. Selectively starving cancer cells through dietary manipulation: methods and clinical implications

    Article • Future Oncology, July 2013, Future Medicine

    Adam Dicker

  104. Using Qualitative Measures to Improve Quality in Radiation Oncology

    Article • American Journal of Medical Quality, July 2013, SAGE Publications

    Adam Dicker

  105. Impact of a Radiation Oncology Elective on the Careers of Young Physicians: Update on a Prospective Cohort Study

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2013, Elsevier

    Adam Dicker

  106. Introduction: The Changing Landscape of Prostate Cancer

    Article • Seminars in Oncology, June 2013, Elsevier

    Adam Dicker

  107. Phase I trials involving radiation therapy, quantifying the risks

    Article • Journal of Medical Imaging and Radiation Oncology, May 2013, Wiley

    Adam Dicker

  108. Ribonucleotide Reductase Expression in Cervical Cancer

    Article • International Journal of Gynecological Cancer, May 2013, Wolters Kluwer Health

    Adam Dicker

  109. Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?

    Article • Cancer Treatment Reviews, May 2013, Elsevier

    Adam Dicker

  110. Dietary Recommendations During and After Cancer Treatment: Consistently Inconsistent?

    Article • Nutrition and Cancer, April 2013, Taylor & Francis

    Adam Dicker

  111. RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients

    Article • International Journal of Radiation Oncology*Biology*Physics, April 2013, Elsevier

    Adam Dicker

  112. β1integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1

    Article • Journal of Cellular Physiology, March 2013, Wiley

    Adam Dicker

  113. Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials

    Article • JNCI Journal of the National Cancer Institute, March 2013, Oxford University Press (OUP)

    Adam Dicker

  114. Predictors of Radiation Oncology Resident Research Productivity

    Article • Journal of the American College of Radiology, March 2013, Elsevier

    Adam Dicker

  115. Outcomes for Patients with Localized Prostate Cancer Treated with Low-Dose-Rate Brachytherapy Seed Implants: The Thomas Jefferson University Hospital Experience

    Article • Brachytherapy, March 2013, Elsevier

    Adam Dicker

  116. Commissioning and implementation of an implantable dosimeter for radiation therapy

    Article • Journal of Applied Clinical Medical Physics, March 2013, Wiley

    Adam Dicker

  117. ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non-Small Cell Lung Cancer Expressing EML4-ALK

    Article • Molecular Cancer Therapeutics, February 2013, American Association for Cancer Research (AACR)

    Adam Dicker

  118. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk

    Article • Prostate Cancer and Prostatic Diseases, February 2013, Nature

    Adam Dicker

  119. A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas

    Article • International Journal of Radiation Oncology*Biology*Physics, February 2013, Elsevier

    Adam Dicker

  120. COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib

    Article • International Journal of Gynecological Cancer, January 2013, Wolters Kluwer Health

    Adam Dicker

  121. Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation

    Article • Frontiers in Oncology, January 2013, Frontiers

    Adam Dicker

  122. Nutrient Restriction and Radiation Therapy for Cancer Treatment: When Less Is More

    Article • The Oncologist, January 2013, Alphamed Press

    Adam Dicker

  123. On the Merits and Limitations of Whole-Brain Radiation Therapy

    Article • Journal of Clinical Oncology, January 2013, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  124. Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis

    Article • Journal of Contemporary Brachytherapy, January 2013, Termedia Sp. z.o.o.

    Adam Dicker

  125. Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610

    Article • Radiation Oncology, January 2013, Springer Science + Business Media

    Adam Dicker

  126. NCI–RTOG Translational Program Strategic Guidelines for the Early-Stage Development of Radiosensitizers

    Article • JNCI Journal of the National Cancer Institute, December 2012, Oxford University Press (OUP)

    Adam Dicker

  127. Salvage radiotherapy for prostate cancer

    Article • Cancer Biology & Therapy, December 2012, Taylor & Francis

    Adam Dicker

  128. Natural language processing (NLP) of Internet conversations to evaluate prostate cancer (PC) patients’ perceptions of active surveillance (AS).

    Article • Journal of Clinical Oncology, December 2012, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  129. Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials.

    Article • Journal of Clinical Oncology, December 2012, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  130. Higher Levels of c-Met Expression and Phosphorylation Identify Cell Lines With Increased Sensitivity to AMG-458, a Novel Selective c-Met Inhibitor With Radiosensitizing Effects

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2012, Elsevier

    Adam Dicker

  131. Quality Assurance Peer Review Chart Rounds in 2011: A Survey of Academic Institutions in the United States

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2012, Elsevier

    Adam Dicker

  132. Radiotherapy Improves Survival in Unresected Stage I–III Bronchoalveolar Carcinoma

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2012, Elsevier

    Adam Dicker

  133. Implementation and experimental results of 4D tumor tracking using robotic couch

    Article • Medical Physics, October 2012, Wiley

    Adam Dicker

  134. Biomarkers of Aging and Radiation Therapy Tailored to the Elderly: Future of the Field

    Article • Seminars in Radiation Oncology, October 2012, Elsevier

    Adam Dicker

  135. Dual Roles of PARP-1 Promote Cancer Growth and Progression

    Article • Cancer Discovery, September 2012, American Association for Cancer Research (AACR)

    Adam Dicker

  136. Towards a Nitinol Actuator for an Active Surgical Needle

    Article • September 2012, ASME International

    Adam Dicker

  137. Reirradiation of recurrent meningioma

    Article • Journal of Clinical Neuroscience, September 2012, Elsevier

    Adam Dicker

  138. Prognostic Factors and Outcomes After Definitive Treatment of Female Urethral Cancer: A Population-based Analysis

    Article • Urology, August 2012, Elsevier

    Adam Dicker

  139. Assessing the Value of an Optional Radiation Oncology Clinical Rotation During the Core Clerkships in Medical School

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Adam Dicker

  140. Implanted Dosimeters Identify Radiation Overdoses During IMRT for Prostate Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Adam Dicker

  141. Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Adam Dicker

  142. Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Adam Dicker

  143. Pilot Study of Meaningful Use of Electronic Health Records in Radiation Oncology

    Article • Journal of Oncology Practice, July 2012, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  144. The Impact of Brachytherapy on Prostate Cancer–Specific Mortality for Definitive Radiation Therapy of High-Grade Prostate Cancer: A Population-Based Analysis

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2012, Elsevier

    Adam Dicker

  145. Reply letter to: Salvage radiotherapy: A plea for dose-escalation with intensity modulated radiotherapy

    Article • European Journal of Cancer, June 2012, Elsevier

    Adam Dicker

  146. Can Drugs Enhance Hypofractionated Radiotherapy? A Novel Method of Modeling Radiosensitization Using In Vitro Data

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2012, Elsevier

    Adam Dicker

  147. IMRT, IGRT, SBRT: Advances in Treatment Planning and Delivery of Radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, May 2012, Elsevier

    Adam Dicker

  148. Abstract 5719: Improvement of radiotherapy for glioblastoma by co-targeting PI3K and HSP90

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Adam Dicker

  149. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling

    Article • European Journal of Cancer, April 2012, Elsevier

    Adam Dicker

  150. A novel curvilinear approach for prostate seed implantation

    Article • Medical Physics, March 2012, Wiley

    Adam Dicker

  151. Mechanical characterization of Polyacrylamide for Prostate Tissue-Mimicking Phantoms

    Article • Journal of Medical Devices, March 2012, ASME International

    Adam Dicker

  152. Electro Thermomechanical Behavior of a Smart Actuator for an Active Surgical Needle

    Article • Journal of Medical Devices, March 2012, ASME International

    Adam Dicker

  153. Differential response of prostate cancer cells to ionizing radiation: The RB status.

    Article • Journal of Clinical Oncology, February 2012, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  154. Physician Beliefs and Practices for Adjuvant and Salvage Radiation Therapy After Prostatectomy

    Article • International Journal of Radiation Oncology*Biology*Physics, February 2012, Elsevier

    Adam Dicker

  155. Characterization and outcomes of optic nerve gliomas: a population-based analysis

    Article • Journal of Neuro-Oncology, January 2012, Springer Science + Business Media

    Adam Dicker

  156. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

    Article • BJU International, January 2012, Wiley

    Adam Dicker

  157. Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions

    Article • Future Oncology, January 2012, Future Medicine

    Adam Dicker

  158. Epidermal Growth Factor Receptor Expression Modulates Antitumor Efficacy of Vandetanib or Cediranib Combined With Radiotherapy in Human Glioblastoma Xenografts

    Article • International Journal of Radiation Oncology*Biology*Physics, January 2012, Elsevier

    Adam Dicker

  159. Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Adam Dicker

  160. Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma

    Article • BMC Genomics, January 2012, Springer Science + Business Media

    Adam Dicker

  161. Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning

    Article • Journal of Contemporary Brachytherapy, January 2012, Termedia Sp. z.o.o.

    Adam Dicker

  162. The Quality of Cervical Cancer Brachytherapy Implantation and the Impact on Local Recurrence and Disease-Free Survival in Radiation Therapy Oncology Group Prospective Trials 0116 and 0128

    Article • International Journal of Gynecological Cancer, January 2012, Wolters Kluwer Health

    Adam Dicker

  163. Improving prognosis of glioblastoma in the 21st century: Who has benefited most?

    Article • Cancer, December 2011, Wiley

    Adam Dicker

  164. Radiation-Induced Toxicity and Radiation Response Modifiers in Zebrafish

    Article • December 2011, Wiley

    Adam Dicker

  165. Postprostatectomy radiation therapy: an evidence-based review

    Article • Future Oncology, December 2011, Future Medicine

    Adam Dicker

  166. A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity

    Article • Circulation Research, October 2011, Wolters Kluwer Health

    Adam Dicker

  167. Post-prostatectomy image-guided radiation therapy: Evaluation of toxicity and inter-fraction variation using online cone-beam CT

    Article • Journal of Medical Imaging and Radiation Oncology, October 2011, Wiley

    Adam Dicker

  168. mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer

    Article • September 2011, Bioscientifica

    Adam Dicker

  169. Patient-Oriented Cancer Information on the Internet: A Comparison of Wikipedia and a Professionally Maintained Database

    Article • Journal of Oncology Practice, September 2011, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  170. The meaning of p16ink4aexpression in tumors

    Article • Cell Cycle, August 2011, Taylor & Francis

    Adam Dicker

  171. In Reply to Dr. King (Adjuvant Radiotherapy After Prostatectomy: Does Waiting for a Detectable Prostate-Specific Antigen Level Make Sense?)

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2011, Elsevier

    Adam Dicker

  172. Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis

    Article • Annals of Oncology, June 2011, Oxford University Press (OUP)

    Adam Dicker

  173. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

    Article • Cancer, June 2011, Wiley

    Adam Dicker

  174. Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704

    Article • The Pharmacogenomics Journal, May 2011, Nature

    Adam Dicker

  175. Intraoperative Planning Increases Feasibility of Prostate Seed Implantation for Small (<20cc) and Large (>50cc) Glands

    Article • Brachytherapy, May 2011, Elsevier

    Adam Dicker

  176. Can the Number of Leftover Seeds Be Reduced? A Study of Prostate Volume, Nomogram, and Delivered Activity for Ultrasound-Guided 125I Prostate Seed Implant

    Article • Brachytherapy, May 2011, Elsevier

    Adam Dicker

  177. Prostate Seed Implantation Alone or With External Beam Radiation Reduces Cause-Specific Mortality Compared to External Beam Radiation Alone for Definitive Treatment of Localized Intermediate- to High-Risk Prostate Cancer: A Population Based Analysis

    Article • Brachytherapy, May 2011, Elsevier

    Adam Dicker

  178. Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic

    Article • Journal of Neuro-Oncology, April 2011, Springer Science + Business Media

    Adam Dicker

  179. Abstract 2662: Radiosensitizing potential of the PI3K inhibitor, BKM-120 and the HSP 90 inhibitor, HSP990, is dependent on PTEN status of glioblastoma cells

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Adam Dicker

  180. Early toxicity predicts long-term survival in high-grade glioma

    Article • British Journal of Cancer, April 2011, Nature

    Adam Dicker

  181. Potential for dose escalation in the postprostatectomy setting with intensity-modulated radiation therapy: a dosimetric study using EORTC consensus guidelines for target volume contours

    Article • Practical Radiation Oncology, April 2011, Elsevier

    Adam Dicker

  182. Introduction

    Article • January 2011, Springer Science + Business Media

    Adam Dicker

  183. Reliability of EUCLIDIAN: An autonomous robotic system for image-guided prostate brachytherapy

    Article • Medical Physics, December 2010, Wiley

    Adam Dicker

  184. Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610

    Article • BJU International, December 2010, Wiley

    Adam Dicker

  185. Decreasing the Adverse Effects of Cancer Therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators

    Article • Clinical Cancer Research, November 2010, American Association for Cancer Research (AACR)

    Adam Dicker

  186. Enhancing Prostate Cancer Care Through the Multidisciplinary Clinic Approach: A 15-Year Experience

    Article • Journal of Oncology Practice, November 2010, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  187. A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate 125I seed implantation

    Article • Brachytherapy, October 2010, Elsevier

    Adam Dicker

  188. From survival to survivorship: late side effects become an issue in high-grade glioma

    Article • Expert Review of Neurotherapeutics, October 2010, Informa Healthcare

    Adam Dicker

  189. Vimentin is a novel AKT1 target mediating motility and invasion

    Article • Oncogene, September 2010, Nature

    Adam Dicker

  190. Reply by the Authors

    Article • Urology, September 2010, Elsevier

    Adam Dicker

  191. Phase I Trial Using Patupilone (Epothilone B) and Concurrent Radiotherapy for Central Nervous System Malignancies

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2010, Elsevier

    Adam Dicker

  192. Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas

    Article • Journal of Clinical Oncology, June 2010, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  193. Abstract 5545: Functional antagonism between vorinostat and temozolomide when combined with ionizing radiation (IR) in glioblastoma

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Adam Dicker

  194. Abstract LB-310: Effects of epidermal growth factor receptor (EGFR) expression on anti-tumor efficacy of vandetanib or cediranib combined with radiotherapy (RT) in U87 human glioblastoma (GBM) xenografts

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Adam Dicker

  195. Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume Effects

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2010, Elsevier

    Adam Dicker

  196. Radiation Dose–Volume Effects in the Brain

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2010, Elsevier

    Adam Dicker

  197. Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma

    Article • Radiation Oncology, January 2010, Springer Science + Business Media

    Adam Dicker

  198. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos

    Article • BMC Developmental Biology, January 2010, Springer Science + Business Media

    Adam Dicker

  199. Smart Needling System for Fully Conformal Radiation Dose Delivery in Treating Prostate Cancer

    Article • January 2010, ASME International

    Adam Dicker

  200. Combination of Vandetanib, Radiotherapy, and Irinotecan in the LoVo Human Colorectal Cancer Xenograft Model

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2009, Elsevier

    Adam Dicker

  201. Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

    Article • Journal of Clinical Oncology, September 2009, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  202. Nuclear factor  B inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos

    Article • Molecular Cancer Therapeutics, September 2009, American Association for Cancer Research (AACR)

    Adam Dicker

  203. Frequency and Correlates of Inappropriate Pediatric Psychiatric Emergency Room Visits

    Article • The Journal of Clinical Psychiatry, August 2009, Physicians Postgraduate Press, Inc

    Adam Dicker

  204. Radiation Therapy Oncology Group Translational Research Program Stem Cell Symposium: Incorporating Stem Cell Hypotheses into Clinical Trials

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2009, Elsevier

    Adam Dicker

  205. Changes in Gene Expression Predicting Local Control in Cervical Cancer: Results from Radiation Therapy Oncology Group 0128

    Article • Clinical Cancer Research, June 2009, American Association for Cancer Research (AACR)

    Adam Dicker

  206. Effect of Percentage of Positive Prostate Biopsy Cores on Biochemical Outcome in Low-risk PCa Treated With Brachytherapy or 3D-CRT

    Article • Urology, June 2009, Elsevier

    Adam Dicker

  207. Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2009, Elsevier

    Adam Dicker

  208. Technique of Outpatient Placement of Intraprostatic Fiducial Markers Before External Beam Radiotherapy

    Article • Urology, April 2009, Elsevier

    Adam Dicker

  209. Comparison of CT vs. ultrasound to determine prostate volume prior to real-time ultrasound based intraoperative planning for 125I seed implantation

    Article • Brachytherapy, April 2009, Elsevier

    Adam Dicker

  210. Ab initio studies of aromatic-aromatic and aromatic-polar interactions in the binding of substrate and inhibitor to dihydrofolate reductase

    Article • International journal of peptide & protein research, January 2009, Wiley

    Adam Dicker

  211. Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

    Article • Gastroenterology, January 2009, Elsevier

    Adam Dicker

  212. Biologically conformal treatment: biomarkers and functional imaging in radiation oncology

    Article • Future Oncology, October 2008, Future Medicine

    Adam Dicker

  213. Combined Vascular Endothelial Growth Factor Receptor/Epidermal Growth Factor Receptor Blockade with Chemotherapy for Treatment of Local, Uterine, and Metastatic Soft Tissue Sarcoma

    Article • Clinical Cancer Research, September 2008, American Association for Cancer Research (AACR)

    Adam Dicker

  214. Image-Guided Radiation Therapy of Prostate Cancer

    Article • May 2008, Taylor & Francis

    Adam Dicker

  215. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341)

    Article • Archives of Gynecology and Obstetrics, May 2008, Springer Science + Business Media

    Adam Dicker

  216. Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo

    Article • Clinical Cancer Research, May 2008, American Association for Cancer Research (AACR)

    Adam Dicker

  217. Inhibition of p73 function by Pifithrin-α as revealed by studies in zebrafish embryos

    Article • Cell Cycle, May 2008, Taylor & Francis

    Adam Dicker

  218. Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45 

    Article • Cancer Research, April 2008, American Association for Cancer Research (AACR)

    Adam Dicker

  219. Hypoxia in prostate cancer: observation to intervention

    Article • The Lancet Oncology, April 2008, Elsevier

    Adam Dicker

  220. M2031 Tumor-Associated Macrophages (TAMS) Are Poor Prognostic Indicators in Pancreatic Cancer

    Article • Gastroenterology, April 2008, Elsevier

    Adam Dicker

  221. Robotic system for image-guided prostate seed implant

    Article • Brachytherapy, April 2008, Elsevier

    Adam Dicker

  222. Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report

    Article • Journal of Medical Case Reports, March 2008, Springer Science + Business Media

    Adam Dicker

  223. Research Highlights

    Article • Therapy, January 2008, Future Medicine

    Adam Dicker

  224. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial

    Article • The Lancet Oncology, October 2007, Elsevier

    Adam Dicker

  225. P4C-2 Contrast Enhanced US for Monitoring the Effect of VEGF Trap on Melanoma Tumor Vascularity

    Article • October 2007, Institute of Electrical & Electronics Engineers (IEEE)

    Adam Dicker

  226. Gene Expression Profiles as Markers of Aggressive Disease—EGFR as a Factor

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2007, Elsevier

    Adam Dicker

  227. Strategic Plans to Promote Head and Neck Cancer Translational Research Within the Radiation Therapy Oncology Group: A Report From the Translational Research Program

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2007, Elsevier

    Adam Dicker

  228. Efficacy and Patterns of Failure for Locally Advanced Cancer of the Cervix Treated With Celebrex (Celecoxib) and Chemoradiotherapy in RTOG 0128

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2007, Elsevier

    Adam Dicker

  229. Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

    Article • Clinical Pharmacology & Therapeutics, May 2007, Nature

    Adam Dicker

  230. Uncemented Total Hip Arthroplasty in Patients with a History of Pelvic Irradiation for Prostate Cancer

    Article • Journal of Bone and Joint Surgery, April 2007, The Journal of Bone and Joint Surgery, Inc.

    Adam Dicker

  231. VEGF Trap in Combination With Radiotherapy Improves Tumor Control in U87 Glioblastoma

    Article • International Journal of Radiation Oncology*Biology*Physics, April 2007, Elsevier

    Adam Dicker

  232. Uncemented Total Hip Arthroplasty in Patients with a History of Pelvic Irradiation for Prostate Cancer

    Article • Journal of Bone and Joint Surgery, April 2007, Wolters Kluwer Health

    Adam Dicker

  233. A Phase II study of acute toxicity for Celebrex™ (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128

    Article • International Journal of Radiation Oncology*Biology*Physics, January 2007, Elsevier

    Adam Dicker

  234. In vivo Radioprotection by the Fullerene Nanoparticle DF-1 as Assessed in a Zebrafish Model

    Article • Clinical Cancer Research, December 2006, American Association for Cancer Research (AACR)

    Adam Dicker

  235. Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2006, Elsevier

    Adam Dicker

  236. Malignant Transformation of Immortalized HaCaT Keratinocytes through Deregulated Nuclear Factor  B Signaling

    Article • Cancer Research, May 2006, American Association for Cancer Research (AACR)

    Adam Dicker

  237. Foreword: Anti-angiogenic therapy: Maximizing therapeutic gain

    Article • International Journal of Radiation Oncology*Biology*Physics, January 2006, Elsevier

    Adam Dicker

  238. Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids

    Article • Nucleic Acids Research, September 2005, Oxford University Press (OUP)

    Adam Dicker

  239. Predicting the Future From Trials of the Past: Epidermal Growth Factor Receptor Expression and Outcome of Fractionated Radiation Therapy Trials

    Article • Journal of Clinical Oncology, August 2005, American Society of Clinical Oncology (ASCO)

    Adam Dicker

  240. E-mail and oncology: a survey of radiation oncology patients and their attitudes to a new generation of health communication

    Article • Prostate Cancer and Prostatic Diseases, April 2005, Nature

    Adam Dicker

  241. Basic and Advanced Techniques in Prostate Brachytherapy

    Article • January 2005, Informa Healthcare

    Adam Dicker

  242. The impact of hormonal therapy on pubic arch interference

    Article • January 2005, Informa Healthcare

    Adam Dicker

  243. Factors predicting for urinary incontinence following prostate brachytherapy

    Article • January 2005, Informa Healthcare

    Adam Dicker

  244. Salvage of suboptimal prostate seed implantation

    Article • January 2005, Informa Healthcare

    Adam Dicker

  245. Can prostate brachytherapy treat potential extraprostatic disease?

    Article • January 2005, Informa Healthcare

    Adam Dicker

  246. Introduction

    Article • January 2005, Informa Healthcare

    Adam Dicker

  247. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade

    Article • Prostate Cancer and Prostatic Diseases, January 2005, Nature

    Adam Dicker

  248. CHK1 affects cell sensitivity to microtubule-targeted drugs

    Article • Journal of Cellular Physiology, January 2005, Wiley

    Adam Dicker

  249. Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers

    Article • International Journal of Radiation Oncology*Biology*Physics, January 2005, Elsevier

    Adam Dicker

  250. Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base

    Article • Brachytherapy, January 2005, Elsevier

    Adam Dicker

  251. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways

    Article • Hematology/Oncology Clinics of North America, October 2004, Elsevier

    Adam Dicker

  252. Factors predicting for urinary incontinence after prostate brachytherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2004, Elsevier

    Adam Dicker

  253. Prostate-Specific Antigen Doubling Time as a Surrogate Marker for Evaluation of Oncologic Drugs to Treat Prostate Cancer

    Article • Clinical Cancer Research, June 2004, American Association for Cancer Research (AACR)

    Adam Dicker

  254. Reanalysis of Cancer Drugs: Old Drugs, New Tricks

    Article • Clinical Cancer Research, June 2004, American Association for Cancer Research (AACR)

    Adam Dicker

  255. Assessment of angiogenesis: implications for ultrasound imaging

    Article • Ultrasonics, April 2004, Elsevier

    Adam Dicker

  256. Foreword: epidermal growth factor receptor (EGFR) inhibitors and cancer therapeutics

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2004, Elsevier

    Adam Dicker

  257. Targeting the EGFR in neoplasia—more questions than answers

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2004, Elsevier

    Adam Dicker

  258. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data

    Article • International Journal of Radiation Oncology*Biology*Physics, March 2004, Elsevier

    Adam Dicker

  259. Involvement of theFhit gene in the ionizing radiation-activated ATR/CHK1 pathway

    Article • Journal of Cellular Physiology, January 2004, Wiley

    Adam Dicker

  260. Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2003, Elsevier

    Adam Dicker

  261. RTOG Symposium COX-2 Inhibitors and Cancer Therapeutics

    Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  262. Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  263. Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  264. Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  265. Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  266. Cyclooxygenase-2 (COX-2) Expression in Human Meningioma as a Function of Tumor Grade

    Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  267. Cyclooxygenase-2 (COX-2) and Epidermal Growth Factor Receptor (EGFR) Expression in Human Pituitary Macroadenomas

    Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  268. COX-2 Inhibitors and Cancer Therapeutics: Potential Roles for Inhibitors of COX-2 in Combination With Cytotoxic Therapy

    Article • American Journal of Clinical Oncology, August 2003, Wolters Kluwer Health

    Adam Dicker

  269. Targeting Angiogenic Processes by Combination Low-Dose Paclitaxel and Radiation Therapy

    Article • American Journal of Clinical Oncology, June 2003, Wolters Kluwer Health

    Adam Dicker

  270. Probability of late rectal morbidity in 125I prostate brachytherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, February 2003, Elsevier

    Adam Dicker

  271. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)

    Article • International Journal of Cancer, January 2003, Wiley

    Adam Dicker

  272. A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy

    Article • Brachytherapy, January 2003, Elsevier

    Adam Dicker

  273. The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy

    Article • The Lancet Oncology, January 2003, Elsevier

    Adam Dicker

  274. Critical evaluation of hormonal therapy for carcinoma of the prostate

    Article • Urology, August 2002, Elsevier

    Adam Dicker

  275. Impact of postimplant edema on V100 and D90 in prostate brachytherapy: can implant quality be predicted on day 0?

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2002, Elsevier

    Adam Dicker

  276. Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results

    Article • Ultrasound in Medicine & Biology, April 2002, Elsevier

    Adam Dicker

  277. Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry

    Article • International Journal of Radiation Oncology*Biology*Physics, December 2001, Elsevier

    Adam Dicker

  278. Defining a future role for radiogenic therapy

    Article • Cancer Treatment Reviews, October 2001, Elsevier

    Adam Dicker

  279. Elevated COX-2 Expression in Cervical Carcinoma

    Article • American Journal of Clinical Oncology, October 2001, Wolters Kluwer Health

    Adam Dicker

  280. Targeting Angiogenic Processes by Combination Rofecoxib and Ionizing Radiation

    Article • American Journal of Clinical Oncology, October 2001, Wolters Kluwer Health

    Adam Dicker

  281. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?

    Article • International Journal of Radiation Oncology*Biology*Physics, July 2001, Elsevier

    Adam Dicker

  282. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer

    Article • Urology, April 2001, Elsevier

    Adam Dicker

  283. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy

    Article • International Journal of Cancer, January 2001, Wiley

    Adam Dicker

  284. The impact of postimplant edema on the urethral dose in prostate brachytherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2000, Elsevier

    Adam Dicker

  285. 182 What are the rectal symptoms after a permanent prostate implant? Evaluation by a patient questionnaire

    Article • Radiotherapy and Oncology, May 2000, Elsevier

    Adam Dicker

  286. 150 Does isotope selection matter for permanent prostate implants? An evaluation of PD-103 vs. I-125 based on radiobiological effectiveness

    Article • Radiotherapy and Oncology, May 2000, Elsevier

    Adam Dicker

  287. 149 Does isotope selection affect urinary symptoms after combined conformal radiotherapy and permanent prostate implant? An evaluation of patients treated with either Pd-103 OR I-125 for implant boost

    Article • Radiotherapy and Oncology, May 2000, Elsevier

    Adam Dicker

  288. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan

    Article • Medical Physics, March 2000, Wiley

    Adam Dicker

  289. Optimum timing for image-based dose evaluation of 125I and 103Pd prostate seed implants

    Article • International Journal of Radiation Oncology*Biology*Physics, November 1999, Elsevier

    Adam Dicker

  290. Effect of post-implant edema on the rectal dose in prostate brachytherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, October 1999, Elsevier

    Adam Dicker

  291. The efficacy of early adjuvant radiation therapy for pt3n0 prostate cancer: a matched-pair analysis

    Article • International Journal of Radiation Oncology*Biology*Physics, August 1999, Elsevier

    Adam Dicker

  292. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, July 1999, Elsevier

    Adam Dicker

  293. The impact of edema on planning 125I and 103Pd prostate implants

    Article • Medical Physics, May 1999, Wiley

    Adam Dicker

  294. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1999, Elsevier

    Adam Dicker

  295. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition

    Article • International Journal of Radiation Oncology*Biology*Physics, July 1998, Elsevier

    Adam Dicker

  296. Effect of edema on the post-implant dosimetry of an I-125 prostate implant: A case study

    Article • International Journal of Radiation Oncology*Biology*Physics, May 1997, Elsevier

    Adam Dicker

  297. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1997, Elsevier

    Adam Dicker

  298. 2209 A biomathematical model for calculating the dose delivered by I-125 or Pd-103 seeds to the edematous prostate

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1997, Elsevier

    Adam Dicker

  299. 2204 Definition of the target volume after radical prostatectomy based on CT driven image fusion technology: Implications for post-operative radiation therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1997, Elsevier

    Adam Dicker

  300. 1009 Edema associated with I-125 or Pd-103 prostate brachytherapy and its effect on post-implant dosimetry: An analysis based on serial CT acquisition

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1997, Elsevier

    Adam Dicker

  301. 2215 Does the urethral angle change with leg position? Implications for urethral-based CT-planned transperineal prostate implants

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1997, Elsevier

    Adam Dicker

  302. Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue

    Article • FEBS Letters, January 1995, Wiley

    Adam Dicker

  303. 100 Risk factors for impotence in patients with carcinoma of the prostate treated with three-dimensional conformal radiation therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, January 1995, Elsevier

    Adam Dicker

  304. Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)

    Article • Nucleic Acids Research, January 1992, Oxford University Press (OUP)

    Adam Dicker

  305. Mutational analysis of humanNRAS genes in malignant melanoma: Rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction

    Article • Genes Chromosomes and Cancer, March 1990, Wiley

    Adam Dicker

  306. Periileostomy Fistulae in Crohnʼs Disease

    Article • Annals of Surgery, February 1983, Wolters Kluwer Health

    Adam Dicker

  307. Noninvasive detection of left ventricular dysfunction with a portable electrocardiographic gated scintillation probe device

    Article • The American Journal of Cardiology, March 1981, Elsevier

    Adam Dicker

  308. Potential for Inhibitors of Cyclooxygenase-2 to Enhance Tumor Radioresponse

    Article • Springer Science + Business Media

    Adam Dicker

  309. Manual and Automated Direct Sequencing of Product Generated by the Polymerase Chain Reaction

    Article • Springer Science + Business Media

    Adam Dicker

  310. Polymerase Chain Reaction Analysis of DNA from Paraffin-Embedded Tissue

    Article • Springer Science + Business Media

    Adam Dicker

  311. Normalization of Tumor Vasculature and Improvement of Radiation Response by Antiangiogenic Agents

    Article • Springer Science + Business Media

    Adam Dicker